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Background: Since bipolar affective disorder has been recorded, clinicians
treating patients with this disorder have noted the cyclic nature of
episodes, particularly an increase in mania in the spring and summer
months and depression during winter.
Objective: The aimof this studywas to investigate seasonality in symptom
onset and service admissions over a period of 10 years in a group of
patients (n ¼ 359) with first-episode (FE) mania (n ¼ 133), FE
schizoaffective disorder (n ¼ 49) and FE schizophrenia (n ¼ 177).
Method: Patients were recruited if they were between 15 and 28 years of
age and if they resided in the geographical mental health service catchment
area. The number of patients experiencing symptom onset and service
admission over each month and season was recorded.
Results: In terms of seasonality of time of service admission, the results
indicate a high overall seasonality (particularly in men), which was
observed in both the schizoaffective and the bipolar groups. In terms of
seasonality of symptomonset, the results indicate that seasonality remains
in the male bipolar group, but other groups have no seasonal trend.
Conclusions: This provides further evidence that systems mediating the
entrainment of biological rhythms to the environment may be more
pronounced in BPAD than in schizoaffective disorder and schizophrenia.
These results may help facilitate the preparedness of mental heath services
for patients at different times of the year.
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Introduction
In the spring,mania,melancholia and epilepsy are apt to
occur.. Many diseases regarded as summer affections
may also occur in the autumn, such as epilepsy, mania
and melancholia (Hippocrates circa 400 BC)
Since descriptions of bipolar affective disorder
(BPAD) have been recorded, professionals treating
patients with this disease have noted the seasonal
nature of the illness, with a general consensus of
increased mania during the spring/summer months
and depression during autumn and winter (1). A
number of theories have been proposed to explain
seasonal recurrence of affective episodes including
those on temperature change (2) and seasonal
psychosocial stressors (such as vacations and ex-
ams) (3). Theories based on changes in light levels
and day lengths have received considerable sup-
port. These theories are based on the assumption of
there being a dual system of circadian entrainment
to the 24-h cycle. This system has an intrinsic
endogenous circadian pacemaker (the suprachias-
matic nucleus of the hypothalamus), which keeps
a cyclic rhythm (generally around 24.5 h). The
second is an exogenous entrainment system that
receives photic (by means of the retinohypothala-
mic tract) and other regulatory input that re-
synchronizes this internal rhythm to the 24-h cycle.
It is argued that either disruption of this daily
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entrainment or shifts in timing of light exposure
may de-synchronize internal circadian rhythms,
leading toaffective episodes (particularly inBPAD)
(1). Sensitivity to environmental changes is best
seen in patients with seasonal affective disorder,
which responds to bright light therapy, who expe-
rience marked depression in winter months (4–8).
In a similar manner, researchers have shown
abnormalities in hormonal responsiveness (ie mel-
atonin) to bright light in patients with BPAD (9–
12). In patients with bipolar disorder, changes in
levels of melatonin are proposed to cause distur-
bances in the circadian rhythm because it is the
primary regulator of the intrinsic circadian pace-
makers (13–19). The disturbance in the association
between external and internal timekeeping hasbeen
postulated to lead to multiple circadian disturban-
ces (20), inparticular, a disruption in the sleep-wake
cycle, which is a precipitant of manic episodes (21–
24). The growing understanding of circadian as-
pects of BPAD has led to the development of
treatments that focus on the normalization of
circadian rhythms (25,26); however, there has been
less focus on the seasonal nature of the illness and
the relevance of this to current treatment ap-
proaches.
Evidence from a number of large-scale studies
provides empirical support for seasonality, with
increased mania and mixed episodes in the spring
(27,28) and summer months (29). Evidence from
studies in the southern hemisphere shows similar
trends for an increase in mania in the spring-
summer (30–33); however, this finding is not
universal (34). One finding shows a spring/
summer peak in the depressive phase of the illness
(2), whereas others indicate autumn increases (35)
or no seasonal variation in depression (34). Fur-
ther studies reveal a bimodal relationship, with
one study on patients with unipolar and bipolar
disorders indicating that seasonality clusters into
one of two patterns: (a) autumn-winter depression
or (b) spring-summer depression (36). In relation
to mania specifically, the studies show two clear
peaks, first in April (ie northern spring) (over 30%
of manic episodes) and then in September (ie
northern autumn) (over 15%). In terms of gender
differences, evidence indicates that seasonality is
generally stronger in men than in women, with the
lattermore likely to display a bimodal distribution
of mania and suicide over different seasons
(33,37). Finally, Takei et al. (38) have shown
seasonality in men and women with mania but
only in women with schizophrenia.
In psychotic disorders, some studies provide
evidence of seasonality of admissions in first-
episode (FE) (38) and overall schizophrenia (39).
More recent studies have providedmixed support,
with one finding no seasonal variation in admis-
sions of patients with either schizophrenia or
bipolar mania (40), another finding a summer
peak in the onset of acute psychotic states (3)
and yet another finding summer peaks that were
variable from year to year (29). A confounding
factor in many of these studies is that the data on
first admission and readmission have rarely been
divided. One of the few studies analyzing this
indicated that in BPAD, first admission and
readmission show a seasonal pattern. However,
in schizophrenia, only first admissions show a sea-
sonal peak (41). Alternatively, other studies found
seasonality in chronic, not in FE, patients with
schizophrenia (42). Combined first and readmis-
sion results are also interfered with by chrono-
biotic (an agent that acts on circadian clocks or
timekeeping functioning to alter rhythmicity) ef-
fects of medications. For example, a clear season-
ality in lithium bioavailability has been shown,
which may cause episode variation between trea-
ted and untreated patients (37).
Overall, reports vary on whether seasonality is
present in patients with BPAD, whether it is more
pronounced in FEs or readmissions and whether
these same trends are observable in other psy-
chotic illnesses. Illness onset and readmission are
not always synchronous and are influenced by
service availability and other variables; the former
may have greater clinical salience. Differences in
seasonality between men and women has been
shown in a number of studies, with results indi-
cating differences in distribution and prevalence
of seasonal changes between genders in different
diagnostic groups; however, no studies have inves-
tigated these differences in an FE cohort. The aim
of this study was to investigate seasonality in
patients using an FE treatment service. The pres-
ence of seasonality was investigated for both the
onset of the manic or psychotic state and the
admission to treatment. Further, seasonality was
investigated according to diagnostic status and
gender. Based on previous studies, it was predicted
that the onset of manic states and admission sea-
son in patientswithBPADwould display the char-
acteristic increase in the spring-summermonths in
contrast to the autumn-winter months. It was
further hypothesized that patients with an FE of
schizophrenia (and schizoaffective disorder) would
display a similar seasonal rise in onset of episode
and admissions. Finally, based on discrepancies in
reports of gender on seasonality, we further tested
whether early reports of greater seasonality inmen
over women was present in patients experiencing
their FE of psychosis or mania.
Seasonality in first-episode mania and psychosis
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Method
Participant details and selection
This study investigated seasonal variation in illness
onset and admission to the treatment program at
the Early Psychosis Prevention and Intervention
Centre (EPPIC). EPPIC is specifically designed for
the treatment of young adults presenting with FE
psychotic disorders aged between 15 and 30 years.
This report used the data from five large cohort
studies conducted at EPPIC between 1989 and
1997, and 2001 and 2005. The demographic details
of the majority of the sample have been described
elsewhere [see Harris et al. (43)]. As research on
seasonality requires studies to be conducted over
12-month periods (to prevent inflated incidence
rates inmonths that aremeasuredmore thanonce),
only data for full 12-month periods from each
study were used. The pooled data in this study
from the five cohorts were drawn from data col-
lected over the period between June 1989 andMay
1992 (12months), February 1993and January 1994
(12 months), February 1995 and January 1996
(12 months), August 1996 and July 1997 (12
months) and October 2001 and September 2005
(60 months).
The second step in the screening process was to
include only participants who met DSM IIIR or
DSM IV-TR criteria for schizophrenia, schizoaf-
fective disorder or BPAD. Based on the exclusion
by a number of the cohort studies, individualswith
other psychosis diagnoses (such as schizophreni-
form) were excluded from the analysis. Diagnoses
were based on the results of the Royal Park
Multidiagnostic Instrument for Psychosis
[McGorry et al. (44)] (for DSM IIIR) or, in the
more recent trial period (2001–2005), the Struc-
tured Clinical Interview for DSM-IV (SCID-I/P)
(45). Both of these tools have high reliability and
validity in diagnosis of psychiatric patients
(44,46,47). Owing to the nature of the EPPIC
program, all participants had psychotic features
(either hallucinations, delusions or both) on entry
to the study, thus giving a sample of the more
severely manic bipolar probands than would be
seen in normal out-patient settings. This sample
did not include individuals in the depressive phase
of BPAD.
After eliminating patients with other diagnoses
(eg brief psychotic disorder, schizophreniform
disorder,major depressionwith psychotic features
and substance-induced psychosis), the study con-
sisted of 359 patients between 14 and 30 years of
age at entry to service (M ¼ 22.18, SD ¼ 3.4). All
patients provided consent for their results to be
used in research conducted at the EPPIC. All five
trials were approved by the institutional ethics
committee and conformed to the National Health
and Medical Research Council guidelines on
studies involving human subjects.
Geographical and catchment area details
The city of Melbourne is situated in Victoria, one
of the most eastern and southern states of
Australia (except Tasmania). Melbourne is lo-
cated at –37.81 latitude and 144.97 longitude.
Seasonal variation in the light-dark cycle differs
widely with sunrise to sunset times during mid-
winter (7:30 a.m. to 5:20 p.m.), while day length is
considerably longer in summer (6:15 a.m. to 8:45
p.m. daylight savings time). Average daily temper-
atures vary between 13C and 26C from mid-
winter to midsummer. The EPPIC treatment
center and in-patient unit are situated just outside
Melbournes central business district (CBD) and
services only individuals within the northwestern
metropolitan catchment area (within 50 km of
Melbourne CBD). Because of the poorer socio-
economic characteristics of the catchment area,
and the consequent limited access to private
psychiatric clinics and psychiatrists, most of the
cohorts living within this catchment area with
mental health issues are treated by theNorthWest
Mental Health Service [see Harrigan et al. (48)].
Within this service, all young adults between 15
and 24 years of age who experience FE psychosis
are referred to and treated by the EPPIC program.
Onset of illness and admission dates
Symptom onset was determined by clinical inter-
view and admission interview data from the
patient and family. Date of onset of symptoms
was considered the timing of a perceptible change
in the patients behaviour. In most files, this
included the onset of the first psychotic symptoms
such as thought disorder and delusions. In the
minority of cases where patients experiencedmore
insidious onset of illness, this was defined from the
family report of when they became aware that
something was wrong with the patient or noticed
a change in the patients behaviour [eg see Owens
and McGorry (49)]. In terms of admission date,
the date of admission to the service was extracted
from relevant patient files.
Statistical analyses
Data were categorized into seasons according
to the following criteria: summer, December to
Hallam et al.
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February; autumn, March to May; winter, June
to August; and spring, September to November.
Monthly data for each diagnostic group were also
recorded to investigate peak incidence of new
admissions. Seasonality was investigated in two
samples of data, both when the patients manic or
psychotic episode begun and when the patient was
admitted to the service as either an in-patient or an
out-patient. This analysis was performed using
non-parametric chi-squared statistics.
For this analysis, data were analyzed as a group
(timing of symptom onset in all patients) and then
into gender effects (all patients). Following this
analysis, the data were split into the subgroups
(schizophrenia, schizoaffective disorder and
BPAD) and finally gender within subgroups. This
same analysis was repeated on the data pertaining
to admission dates. The error rate was set at a ¼
.05 for the tests in these two sets of analyses.
Results
The variations in symptom onset across seasons
are presented in Table 1 for schizophrenia, schizo-
affective disorder and BPAD by gender.
The results indicate no overall seasonal trend in
timing of symptom onset across these diagnostic
groups. Further, although there is some indication
of an overall trend of seasonality in men, gender
effects within diagnostic groups are not evident.
Themostmarked result on analyzing the results in
Table 1 is the strong evidence for a significant
seasonality in the bipolar group, with patients
displaying marked increases in onset of symptoms
in spring and lowest incidence in the autumn
months.
Figure 1 shows the variation from percentage of
expected episodes across the 12-month period.
This type of graph develops an expected percent-
age of episode onsets within a given month based
on a uniform pattern. Variations in number of
admissions from this pattern are then expressed as
a percentage change from this predicted incidence
for each of the 12 months for patients with
schizophrenia or BPAD. Patients with schizoaf-
fective disorder were not included in this repre-
sentation because of low sample size.
Figure 1 indicates a considerable peak in the
months of August, September and October in the
bipolar patient group, consistent with a seasonal
variation suggested in Table 1. Although this
variation is detected by the seasonal analysis, there
is no evidence of acute changes between individual
months from the statistical analysis (w2 ¼ 16.684,
df ¼ 11, p ¼ 0.118). In terms of the schizophrenia
group, although there are no seasonal effects,
there is a significant change in monthly onset
across different months (w2¼ 20.220, df¼ 11, p¼
0.042). Figure 1 indicates that there are discrete
increases in symptom onset around December,
June, July and August, with lower than expected
numbers of new patients exhibiting symptoms in
January, April and September. Overall, these
data indicate that monthly variation in symptom
onset in patients with schizophrenia is non-
systematic, in contrast to the more systematic
changes observed in patients with bipolar disorder.
For the admission data, the results of the
seasonal analysis are presented in Table 2.
The results indicate a significant overall sea-
sonal trend in admissions to the EPPIC treatment
service for all groups of psychosis. These results
appear to be more robust in men than in women.
The strength of this gender effect is amplified in
the bipolar group where men had a significant
seasonal variation, while women showed a more
Table 1. Symptom onset of mania or psychosis by diagnosis and gender
Diagnostic
group Group n Summer Autumn Winter Spring Statistics
Overall 359 81 75 99 104 w2(3) ¼ 6.493, p ¼ 0.090
Male 258 56 51 77 74 w2(3) ¼ 7.767, p ¼ 0.051
Female 101 25 24 22 30 w2(3) ¼ 1.367, p ¼ 0.711
Schizophrenia Overall 177 44 36 53 44 w2(3) ¼ 3.271, p ¼ 0.352
Male 141 33 29 46 33 w2(3) ¼ 4.674, p ¼ 0.197
Female 36 11 7 7 11 w2(3) ¼ 1.778, p ¼ 0.620
Schizoaffective Overall 49 7 13 16 13 w2(3) ¼ 3.490, p ¼ 0.322
Male 33 5 6 12 10 w2(3) ¼ 3.970, p ¼ 0.265
Female 16 2 7 4 3 w2(3) ¼ 3.500, p ¼ 0.321
Bipolar Overall 133 30 26 30 47 w2(3) ¼ 7.902, p ¼ 0.048*
Male 84 18 16 19 31 w2(3) ¼ 6.571, p ¼ 0.087
Female 49 12 10 11 16 w2(3) ¼ 1.694, p ¼ 0.638
*Significant difference at p = .05.
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Fig. 1. Radar graph showing monthly percentage difference
scores in symptom onset cases (from steady rate of new cases
of symptomonset) for patients withBPADand schizophrenia.
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consistent presentation over the year. Although
this difference in seasonality was strongest in the
bipolar group, it was also present in the schizo-
affective group. The monthly breakdown of the
change from expected percentage of admissions is
presented in Fig. 2 for the schizophrenia and
bipolar groups.
The results of the radar graph indicate that the
peak in EPPIC admissions for BPAD and schizo-
phrenia occur in the latewinter (August) and spring
months (except September in the bipolar group),
with considerably lower rates in the summer
months. There is also a strong peak in admissions
of patients with bipolar disorder in May, the final
monthof autumn.More specifically, analysis of the
12-month variation data indicated that there was
a very marked variation in admissions in the
bipolar group (w2(11) ¼ 26.789, p ¼ 0.005).
Figure 2 indicates that this variation is associated
with the peak in admissions in October, Novem-
ber and December and an acute increase again in
May. In the schizophrenia group, only a trend for
monthly variations was detected for admission
data (w2(11) ¼ 18.051, p ¼ 0.080). Again, small
sample size in the schizoaffective group prevented
further analysis. Overall, the peak admissions
occurred in September for schizophrenia (11.7%
of yearly schizophrenia admissions), in August
for schizoaffective disorder (14.5%) and in
October for BPAD (14.3%).
Discussion
The results of this study indicate that first admis-
sions for psychosis show a seasonal pattern.When
split by diagnostic category, the results indicate
a seasonal pattern in all three conditions; however,
the timing of peaks appears to vary across disor-
ders. More specifically, admissions of patients
with schizophrenia peak in spring and those for
the schizoaffective group a little earlier in winter
and early spring, whereas admissions for bipolar
group peak later in the spring and summer peri-
ods. The monthly breakdown of these data in-
dicates that the peak incidence of admissions for
these disorders occurs in different months accord-
ing to diagnosis, with earliest onset in August for
schizophrenia, in September for schizoaffective
disorder and in October for BPAD. The presence
of these seasonal effects concurs with the results of
the previous studies (30–33).
Notably in the bipolar group, there is a large
jump in admissions during May within the
autumn-winter transition that is markedly in-
creased compared with admissions immediately
preceding and following this month. Further, this
autumn-winter increase appears unique to the
bipolar group as there is no evidence of increased
admissions in the schizophrenia or schizoaffective
group. This provides further support for theories
that acute episode onset in BPAD may show
abimodal distribution (36) and inmania, a smaller
and more concentrated peak in late autumn and
a more significant and prolonged increase over
spring and summer.
In relation to the hypothesis that onset of
symptoms would also show a seasonal variation,
the results of the current study weremixed. Unlike
Owens and McGorry (49), we did not find an
overall seasonal effect but did detect a marked
increase in symptom onset in December, June,
July and August, in contrast to lower than ex-
pected numbers of newpatients showing symptom
onset in January, April and September. However,
–8.0
–4.0
0.0
4.0
8.0D
J
F
M
A
M
J
J
A
S
O
N
Schizophrenia
Bipolar Disorder
Fig. 2. Radar graph showing monthly percentage difference
scores in new admissions (from steady rate) for patients with
BPAD and schizophrenia.
Table 2. Results of seasonality of admission by gender and group
Diagnostic
group Group n Summer Autumn Winter Spring Statistics
Overall 359 78 71 85 125 w2(3) ¼ 19.552, p < 0.001**
Male 258 51 52 62 93 w2(3) ¼ 17.938, p < 0.001**
Female 101 27 19 23 32 w2(3) ¼ 3.673, p ¼ 0.299
Schizophrenia Overall 177 39 39 38 61 w2(3) ¼ 8.469, p ¼ 0.037*
Male 141 30 31 33 47 w2(3) ¼ 5.355, p ¼ 0.148
Female 36 9 8 5 14 w2(3) ¼ 4.667, p ¼ 0.198
Schizoaffective Overall 49 7 7 18 17 w2(3) ¼ 9.041, p ¼ 0.029*
Male 33 5 5 11 12 w2(3) ¼ 5.182, p ¼ 0.159
Female 16 2 2 7 5 w2(3) ¼ 4.500, p ¼ 0.212
Bipolar Overall 133 32 25 29 47 w2(3) ¼ 8.323, p ¼ 0.040*
Male 84 16 16 18 34 w2(3) ¼ 10.857, p ¼ 0.013*
Female 49 16 9 11 13 w2(3) ¼ 2.184, p ¼ 0.535
*Significant difference at alpha of .05.
**Significant difference at alpha of .01.
Hallam et al.
158
https:/www.cambridge.org/core/terms. https://doi.org/10.1111/j.1601-5215.2006.00147.x
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 21:14:32, subject to the Cambridge Core terms of use, available at
it is also apparent that there aremore patients with
schizophrenia who experience symptom onset
around the winter months. In terms of the bipolar
group, a strong seasonal trend for increased
symptom onset in spring is evident.
In relation to the hypothesis of gender differ-
ences in seasonality, the results indicate that,
overall, men may be more vulnerable to seasonal
effects than women. In fact, while men tended to
show the characteristic increase in spring admis-
sions, women tended to show a much blunter
increase that failed to reach significance. Analysis
based on gender by group is somewhat limited
because of the small sample of women in relation
to overall sample size (eg in the schizophrenia
group, 141 of the 177 patients were men). This
said, data in both the schizophrenia and the
bipolar groups showed a significant seasonal trend
for increased spring admissions in men but no
significant seasonal effects in women. Gender
effects in the schizoaffective group were not
evident; however, this group had particularly
small numbers.
One of the strengths of the current study is that
it investigated only FE admissions, rather than
readmissions to hospital. This method eliminates
the effect of variability in the number of readmis-
sions in serious psychosis associated with relapse
and controls for treatment effects. Theoretically,
the other advantage of examining FE psychosis is
the absence of chronicity. According to a number
of staging (50) and kindling theories (51) ofmental
illnesses, it is assumed that there are a number of
neurobiological changes associated with disease
progression that phenomenologically change the
symptoms, altering the relative contribution of
extrinsic and intrinsic factors. For instance, in
patients with BPAD, episode frequency and sever-
ity increase as the disease progresses and become
less associated with identifiable environmental
stressors and therefore more intrinsic. An addi-
tional advantage of this study design is the timing
of symptom onset and admission to treatment ser-
vices. This overcomes the flaws of previous studies
that only considered admission times as it is ack-
nowledged that in some disorders, a considerable
time may elapse between onset of symptoms and
clinical presentation (eg schizophrenia), whereas
in others, illness state may deteriorate rapidly (ie
mania in patients with bipolar disorder).
Elements limiting the generalizability of these
results also warrant attention. First, although
assessment of onset date was based on multiple
sources and was defined with as much preciseness
as possible, it is nevertheless retrospectively deter-
mined. This may increase the likelihood of error
in estimating onset, which could hinder the obser-
vation of a seasonality in onset time. Second,
admission time, although a valid proxy of varia-
tions in illness intensity, is also dependent on
various other elements that are not directly related
to the disorder itself, which may confound results.
Finally, the relatively small sample size limits the
power of our findings.
Overall, these data may have implications for
service delivery to these populations. In particular,
clinicians working with patients with mania may
benefit from increased vigilance for manic symp-
toms around the late winter and spring months.
Further, inpatientswitha seasonal patternof illness,
cliniciansmayprovidemore effective treatmentwith
a program that includes components addressing
social and biological rhythm regularity. One such
program is the interpersonal and social rhythm
therapy, which has shown some efficacy in treating
patients with BPAD (52–54). It may be useful to
investigate whether the patients benefiting from this
type of program are also those who display seasonal
forms of the illness, hence indicating that the
treatment addressed a biological vulnerability in this
group. In those patients particularly vulnerable to
environmental influences, alterations to the combi-
nations or dose of medications may be particularly
useful. Previous studies indicate that some medica-
tions such as lithium and valproate (mood stabil-
izers) have chronobiotic activity (ie assist in
normalizing circadian rhythms) (9,55,56). Recent
evidence indicates that this chronobiotic effect may
bemediated through intracellular glucogen synthase
kinase (GSK) 3b and clock gene activation (37,57–
61). Ongoing research in both clinical populations
and preclinical models [ie animal paradigms of
circadian and seasonal rhythms such as sheep and
rabbits (62,63)] is required to determine the genetic
and molecular basis of these variations in clinical
populations. Converging evidence from the chrono-
biotic activity ofmood stabilizers, seasonal variation
in their bioavailability and these results indicating
the seasonal natureofBPADinearly stagesof illness
indicate a biological vulnerability in these patients in
the system/s that control rhythmicity.
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